Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2025-12-24 @ 9:49 PM
NCT ID:
NCT05905432
Eligibility Criteria:
Inclusion Criteria :
* Healthy male and female volunteers aged 18-45 years.
* Able and willing (in the investigator's opinion) to comply with all trial requirements.
* General good health based on medical history and clinical examination.
* Written informed consent.
* Available to participate in follow up for the duration of trial (6 months following the last injection).
* Reachable by phone during the whole trial period.
* Women only: Must agree to practice continuous effective contraception for the duration of the trial.
Exclusion Criteria:
* Positive for P. falciparum sexual and asexual stages by thick blood smear microscopy on admission and documented parasitologically confirmed malaria parasites of at least 1000 parasite/microliter in the past four weeks.
* Pregnancy, lactation, or intention to become pregnant during the trial.
* Previous participation in a malaria vaccine trial.
* HIV and microscopically detectable schistosomiasis and Soil-Transmitted helminth infection.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT05905432
Study Brief:
Protocol Section:
NCT05905432